Amniotic Membrane Market, by Product Type (Amniotic Membranes {Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes}, and Amniotic Suspensions), by Application (Wound Care, Orthopedics, Ophthalmology, and Others), by End User (Hospitals, Amb

Amniotic Membrane Market, by Product Type (Amniotic Membranes {Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes}, and Amniotic Suspensions), by Application (Wound Care, Orthopedics, Ophthalmology, and Others), by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach or by an advanced suture-less approach as well. AMT can be used to protect damaged tissues, stimulate growth of new cells, and reduce inflammation and pain by decreasing friction in the eyelids. According to a study published by the National Center for Biotechnology Information (NCBI) in February 2021, 94.3% of people who had undergone amniotic membrane transplant reported of healed epithelial defects while 88% people reported symptomatic relief from symptoms such as dryness, discomfort and pain.

Market Dynamics

Market players are focused on research and development activities to obtain approvals for novel products or techniques associated with amniotic membrane, this could contribute to the growth of the market over the forecast period. For instance, in 2018, MiMedx, an American biomedical company received the status of Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Administration for its product AmnioFix, an amniotic membrane that is designed for use in osteoarthritis treatment.

Market players are focusing on product launches, which is expected to strengthen their position in the global market. For instance, on February, 2021, Integra LifeSciences, an American medical technology company launched AmnioExcel Plus amniotic membrane that helps in wound care.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the amniotic membrane market globally. For instance, in 2017, Organogenesis Holdings Inc., an American regenerative medicine company acquired NuTech Medical, an American biologics company, to expand their company product portfolio and support the development of next generation amniotic membrane products.

Key features of the study:
This report provides an in-depth analysis of global amniotic membrane market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global amniotic membrane market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global amniotic membrane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the amniotic membrane market
Detailed Segmentation:
Global Amniotic Membrane Market, By Product Type:
Amniotic Membranes
Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes
Amniotic Suspensions
Global Amniotic Membrane Market, By Application:
Wound Care
Orthopedics
Ophthalmology
Others
Global Amniotic Membrane Market, By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes
Global Amniotic Membrane Market, By Region:
North America
By Product Type:
Amniotic Membranes
Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes
Amniotic Suspensions
By Application:
Wound Care
Orthopedics
Ophthalmology
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes
By Country:
U.S.
Canada
Latin America
By Product Type:
Amniotic Membranes
Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes
Amniotic Suspensions
By Application:
Wound Care
Orthopedics
Ophthalmology
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Amniotic Membranes
Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes
Amniotic Suspensions
By Application:
Wound Care
Orthopedics
Ophthalmology
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Amniotic Membranes
Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes
Amniotic Suspensions
By Application:
Wound Care
Orthopedics
Ophthalmology
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East
By Product Type:
Amniotic Membranes
Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes
Amniotic Suspensions
By Application:
Wound Care
Orthopedics
Ophthalmology
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Amniotic Membranes
Cryopreserved Amniotic Membranes
Dehydrated Amniotic Membranes
Amniotic Suspensions
By Application:
Wound Care
Orthopedics
Ophthalmology
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Smith & Nephew*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Applied Biologics
Organogenesis Holdings Inc.
Osiris Therapeutics, Inc.
Alliqua BioMedical, Inc.
Amnio Technology, LLC
Next Biosciences
Integra LifeSciences
MiMedx
LifeCell International
Human Regenerative Technologies, LLC
Amniox Medical, Inc.
Skye Biologics Inc.
Wright Medical
TissueTech
Katena Products, Inc.
NuVision Biotherapies
Surgenex
Ventris Medical

“*” marked represents similar segmentation in other categories in the respective section.